R&D Scouting in Pharma: Turning Leads into Value, Barcelona (SP)

28-30 November, 2016. This marcus evans conference will provide practical case studies on scouting strategies and beyond, in order to select and evaluate research leads, accelerate the process to turn them into value and future projects.
Facing huge changes in its development model, pharmaceutical industry needs to reorganize at large its R&D strategy, to reduce its costs and tap the potential of external innovation. Scouting is becoming crucial as it helps pharma seeking out local promising new biology that can form the basis for innovative drug-discovery programs. But one of the main challenges resides also in transforming promising biology into development potential, scaling up science to long term sustainable projects. Pharma needs to have the right capacities and clear organization structure and tools to accompany and integrate innovation into business, foster research through partnership, entrepreneurship and innovative science hubs.